Deveron Reports Annual and Special Meeting Results
Toronto, Ontario–(Newsfile Corp. – July 28, 2023) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
Toronto, Ontario–(Newsfile Corp. – July 28, 2023) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research that analyzes nonperforming loan (NPL) transactions issued following the global…
Company recognized as a Best Place to Work for Disability Inclusion RADNOR, Pa.–(BUSINESS WIRE)–Lincoln Financial…
New collaboration reflects companies’ shared commitment to addressing customers’ data complexity and infrastructure modernization challenges…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage…
LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Presentations represent the first time clinical data regarding ARX517 will be presented at a medical…
Presentations represent the first time clinical data regarding ARX517 will be presented at a medical…
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
SAN DIEGO, July 28, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate…
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa”…
Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX) (“Biodexa”…
Media Release SYDNEY, AUSTRALIA, July 28, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ:…
Media Release SYDNEY, AUSTRALIA, July 28, 2023 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ:…
Ms. Sullivan brings her extensive commercialization, strategy, and market access experience to the Lexicon Board…
Ms. Sullivan brings her extensive commercialization, strategy, and market access experience to the Lexicon Board…